Stocks › RDHL

RedHill Biopharma Ltd.

RDHL·Nasdaq·Israel Israel·USD
$0.49
-0.01 (-1.44%)
Close · Oct 5, 2026 · Close Prices from Tiingo.com
RDHL
RedHill Biopharma Ltd. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
RDHLS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of RDHL by members of U.S. Congress · 0 on record

No congressional trades in RDHL on record.

Whale Activity

Position changes in RDHL reported for 2026-06-30 by 1 tracked institutional filer
Increased: 1
  • Increased1
  • New0
  • Held0
  • Decreased0
  • Closed0
  • No prior filing0
FilerSharesValueChange
CITADEL ADVISORS LLC65.3K$55Kincreased

KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.

Insider Trading

Net shares bought (+) or sold (−) on the open market by RDHL insiders, by quarter · Form 4
-20.0M-10.0M010.0M20.0M2025 Q1: 02025 Q12025 Q2: 02025 Q22025 Q3: 02025 Q32025 Q4: 02025 Q42026 Q1: 02026 Q12026 Q2: -15.7M2026 Q22026 Q3: -14.1M2026 Q32026 Q4: -14.3M2026 Q4

Recent Insider Transactions

3 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Raday GileadChief Operating Officer Sale −14.3M n/c — Oct 1, 2026 Form 4 ↗
Raday GileadChief Operating Officer Sale −14.1M n/c — Jul 10, 2026 Form 4 ↗
Raday GileadChief Operating Officer Sale −15.7M $0.00 $0 Apr 6, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding RDHL · SEC Form N-PORT

No mutual fund or ETF has reported RDHL in an N-PORT filing in the last seven months.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings

No 13D/13G beneficial-ownership filings on record.

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming RedHill Biopharma Ltd. as client

No lobbying filings found naming RedHill Biopharma Ltd. as the client.

Government Contracts

Federal awards to RedHill Biopharma Ltd. · USAspending

No federal contract awards found for RedHill Biopharma Ltd..

U.S. Patents

Recent USPTO applications naming RedHill Biopharma Ltd.

No USPTO patent applications found for RedHill Biopharma Ltd..

Annual Financials

From RDHL's 10-K filings · XBRL

No annual XBRL figures on record for RDHL. KeyVex's fundamentals cover about 130 large companies so far.

Stock Splits

Every split and reverse split in the price history
  • 1-for-25Reverse splitAug 20, 2024
  • 1-for-40Reverse splitMar 23, 2023

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC

No 8-K filings on record.

About RedHill Biopharma Ltd.

From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersTEL AVIV, Israel
IncorporatedL3